CN116531461A - Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof - Google Patents
Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof Download PDFInfo
- Publication number
- CN116531461A CN116531461A CN202211701120.5A CN202211701120A CN116531461A CN 116531461 A CN116531461 A CN 116531461A CN 202211701120 A CN202211701120 A CN 202211701120A CN 116531461 A CN116531461 A CN 116531461A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- double coptis
- epidemic prevention
- nasal spray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000007922 nasal spray Substances 0.000 title claims abstract description 37
- 229940097496 nasal spray Drugs 0.000 title claims abstract description 37
- 230000002265 prevention Effects 0.000 title claims abstract description 30
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 30
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 28
- 241000037740 Coptis chinensis Species 0.000 title claims abstract description 24
- 239000000668 oral spray Substances 0.000 title claims description 15
- 229940041678 oral spray Drugs 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 151
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 28
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000003880 Calendula Nutrition 0.000 claims abstract description 26
- 240000004385 Centaurea cyanus Species 0.000 claims abstract description 26
- 235000005940 Centaurea cyanus Nutrition 0.000 claims abstract description 26
- 241000233855 Orchidaceae Species 0.000 claims abstract description 25
- 229940001884 passion flower extract Drugs 0.000 claims abstract description 25
- 235000020689 passion flower extract Nutrition 0.000 claims abstract description 25
- 229940064064 purslane extract Drugs 0.000 claims abstract description 24
- 241000218202 Coptis Species 0.000 claims abstract description 22
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 22
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 20
- LTTQKYMNTNISSZ-MWTRTKDXSA-N (2S)-(-)-kurarinone Chemical compound C1([C@H]2OC=3C(C[C@@H](CC=C(C)C)C(C)=C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1O LTTQKYMNTNISSZ-MWTRTKDXSA-N 0.000 claims abstract description 20
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 20
- 229940036350 bisabolol Drugs 0.000 claims abstract description 20
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 20
- XQVFLLMCNGKXSM-UHFFFAOYSA-N kurarinone Natural products COc1cc(O)c(C(CC=C(C)C)C(=C)C)c2OC(CC(=O)c12)c3ccc(O)cc3O XQVFLLMCNGKXSM-UHFFFAOYSA-N 0.000 claims abstract description 20
- KDADHLPROOOPIC-UHFFFAOYSA-N neokurarinol Natural products COc1cc(O)ccc1C1CC(=O)c2c(OC)cc(O)c(CC(CCC(C)(C)O)C(C)=C)c2O1 KDADHLPROOOPIC-UHFFFAOYSA-N 0.000 claims abstract description 20
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 20
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 239000007921 spray Substances 0.000 claims abstract description 16
- 210000000214 mouth Anatomy 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 240000001432 Calendula officinalis Species 0.000 claims abstract 9
- 244000269722 Thea sinensis Species 0.000 claims abstract 7
- 241000576429 Forsythia suspensa Species 0.000 claims description 16
- 239000009254 shuang-huang-lian Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005070 sampling Methods 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 230000009545 invasion Effects 0.000 claims description 2
- 210000003928 nasal cavity Anatomy 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims 6
- 240000004534 Scutellaria baicalensis Species 0.000 claims 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 241000050051 Chelone glabra Species 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 12
- 244000052616 bacterial pathogen Species 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 230000001681 protective effect Effects 0.000 abstract description 3
- 241000711573 Coronaviridae Species 0.000 abstract description 2
- 230000005540 biological transmission Effects 0.000 abstract description 2
- 230000002147 killing effect Effects 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract description 2
- 241000132025 Calendula Species 0.000 description 17
- 241001122767 Theaceae Species 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 230000002433 effect on respiration Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- -1 triterpene compounds Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray and a preparation method thereof, comprising a spray bottle and double coptis chinensis composition, wherein the double coptis chinensis composition is prepared from the following raw materials: honeysuckle extract, baical skullcap root extract, weeping forsythiae extract, passion flower extract, calendula extract, cornflower extract, orchid extract, bisabolol, kurarinone, purslane extract and tea polyphenol. The epidemic prevention and sterilization double coptis composition oral-nasal spray is prepared from raw materials with sterilization effects such as honeysuckle extract, baical skullcap root extract, weeping forsythiae capsule extract, passion flower extract, calendula extract, cornflower extract, orchid extract, purslane extract and the like, can be applied to the oral cavity and the nasal and can continuously kill germs in inhaled air, and a protective net is arranged at the oral cavity and the nasal to protect the health of a human body. The invention has stronger killing effect on various common pathogens and also has inhibiting effect on the transmission of the new coronavirus.
Description
Technical Field
The invention relates to the technical field of application of traditional Chinese medicines, in particular to an epidemic prevention and sterilization double coptis composition oral and nasal spray and a preparation method thereof.
Background
The Shuanghuanglian is prepared from honeysuckle, baical skullcap root and weeping forsythiae capsule, has the effects of dispelling wind and relieving exterior syndrome, and clearing heat and detoxicating, and is used for treating common cold caused by exogenous wind-heat, and symptoms such as fever, cough and pharyngalgia. Meanwhile, the double coptis chinensis has strong antibacterial and bactericidal effects and has certain effects on common germs. The mouth and nose are used as the respiratory system of human body, the contact with the environment is unavoidable, many infectious diseases are transmitted through air, spray or aerosol, the mouth and nose spray is silent and is inadvisable, the situation that people breathe unsmoothly and the like can be caused by wearing the mask for a long time, and the quality of the mask is different, so that the protection effect is unsatisfactory, therefore, the mouth and nose spray of the Shuanghuanglian composition for epidemic prevention and sterilization and the preparation method thereof are provided.
Disclosure of Invention
The invention aims to overcome the existing defects, provides an epidemic prevention and sterilization double coptis composition oral-nasal spray and a preparation method thereof, adopts honeysuckle extract, baical skullcap root extract and weeping forsythiae extract to compound other raw materials with sterilization effect to prepare the oral-nasal spray which is applied to the oral-nasal spray and can continuously kill germs in inhaled air, and a protective net is arranged at the oral-nasal spray to protect the health of human bodies, so that the problems in the background technology can be effectively solved.
In order to achieve the above purpose, the present invention provides the following technical solutions:
the epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray comprises a spray bottle and double coptis chinensis compositions, wherein the double coptis chinensis compositions are prepared from the following raw materials:
honeysuckle extract, baical skullcap root extract, weeping forsythiae extract, passion flower extract, calendula extract, cornflower extract, orchid extract, bisabolol, kurarinone, purslane extract and tea polyphenol.
Further, the Shuanghuanglian composition is prepared from the following raw materials in parts by weight:
20-30 parts of honeysuckle extract, 10-20 parts of baical skullcap root extract, 10-20 parts of weeping forsythia extract, 8-15 parts of passion flower extract, 5-10 parts of calendula extract, 3-5 parts of cornflower extract, 2-4 parts of orchid extract, 0.4-0.8 part of bisabolol, 0.3-0.6 part of kurarinone, 1-3 parts of purslane extract and 0.03-0.05 part of tea polyphenol.
Further, the Shuanghuanglian composition is prepared from the following raw materials in parts by weight:
20 parts of honeysuckle extract, 20 parts of baical skullcap root extract, 10 parts of weeping forsythia extract, 14 parts of passion flower extract, 5 parts of calendula extract, 5 parts of cornflower extract, 2 parts of orchid extract, 0.7 part of bisabolol, 0.3 part of kurarinone, 3 parts of purslane extract and 0.03 part of tea polyphenol.
Further, the Shuanghuanglian composition is prepared from the following raw materials in parts by weight:
25 parts of honeysuckle extract, 15 parts of baical skullcap root extract, 15 parts of weeping forsythia extract, 12 parts of passion flower extract, 7 parts of calendula extract, 4 parts of cornflower extract, 3 parts of orchid extract, 0.6 part of bisabolol, 0.4 part of kurarinone, 2 parts of purslane extract and 0.04 part of tea polyphenol.
Further, the Shuanghuanglian composition is prepared from the following raw materials in parts by weight:
30 parts of honeysuckle extract, 10 parts of baical skullcap root extract, 20 parts of weeping forsythia extract, 10 parts of passion flower extract, 10 parts of calendula extract, 3 parts of cornflower extract, 4 parts of orchid extract, 0.5 part of bisabolol, 0.6 part of kurarinone, 1 part of purslane extract and 0.05 part of tea polyphenol.
Further, the honeysuckle extract, the baical skullcap root extract, the weeping forsythiae capsule extract, the passion flower extract, the calendula extract, the cornflower extract, the orchid extract and the purslane extract are extracted by ethanol with the concentration of 34-60 percent.
Furthermore, the particle size distribution of the epidemic prevention and sterilization double coptis composition oral-nasal spray is that the percentage of fog drops with the particle size distribution of 2-5 μm to the total volume of the fog drops is more than 75%.
Further, the product is used for disinfection and bacteriostasis at the oral cavity and the nasal cavity, and can prevent bacterial or virus invasion infection.
The preparation method of the epidemic prevention and sterilization double coptis composition oral-nasal spray comprises the following steps:
s1, mixing a honeysuckle extract, a baical skullcap root extract, a weeping forsythia extract, a passion flower extract, a calendula extract, a cornflower extract, an orchid extract and a purslane extract at normal temperature, and homogenizing;
s2, adding bisabolol, kurarinone and tea polyphenol into the mixed solution, and stirring slowly until the mixture is homogeneous;
s3, performing a sampling test, and filling the qualified product into a spray bottle.
In S1 and S2, the stirring speed is 20-40r/min.
Compared with the prior art, the invention has the beneficial effects that: the epidemic prevention and sterilization double coptis composition oral-nasal spray and the preparation method thereof have the following advantages:
the antibacterial raw materials such as honeysuckle extract, baical skullcap root extract, weeping forsythiae extract, passion flower extract, calendula extract, cornflower extract, orchid extract, purslane extract and the like are used for preparing the antibacterial raw materials which are applied to the mouth and nose and can continuously kill germs in inhaled air, and a protective net is arranged at the mouth and nose to protect the health of a human body.
The passion flower extract, calendula extract and cornflower extract are added, so that the bitter taste of the double coptis spray is improved, the whole taste and smell are more acceptable to users, and the Chinese medicinal composition has strong killing effect on various common pathogens and also has inhibiting effect on the transmission of new coronaviruses.
The raw materials are all pure plant sources, so that the use safety is high, and the sterilization effect is good.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The invention provides the following technical scheme:
the epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray comprises a spray bottle and double coptis chinensis compositions, wherein the double coptis chinensis compositions are prepared from the following raw materials:
honeysuckle extract, baical skullcap root extract, weeping forsythiae extract, passion flower extract, calendula extract, cornflower extract, orchid extract, bisabolol, kurarinone, purslane extract and tea polyphenol.
The experiment shows that the honeysuckle has an inhibiting effect on typhoid bacillus, paratyphoid bacillus, escherichia coli, proteus, pseudomonas aeruginosa, pertussis bacillus, vibrio cholerae, staphylococcus, streptococcus, pneumococcus, meningococcus and the like; the honeysuckle extract has remarkable stimulation effect on respiration of drug-resistant staphylococcus aureus plants, and is mainly used for internal medicine and surgical inflammation caused by drug-resistant bacteria, such as treatment of pulmonary tuberculosis complicated with respiratory tract infection, pneumonia, acute bacillary dysentery and diarrhea. It is also used to reduce the loading rate of the throat; radix Scutellariae has antibacterial, antiviral, antiinflammatory, immunity improving, and antipyretic effects; fructus forsythiae has the effects of clearing heat, resolving hard mass, curing scrofula tuberculosis, clearing heart fire, promoting urination, sore and carbuncle, heat stranguria and pain, excessive heat toxin and bacteriostasis and sterilization; passion flower contains tannic acid, has various crude drug components such as plant pectin, tri-glycoside saponin, alkaloid and the like, has astringent effect, and can lubricate and moisten skin, has the effects of moisturizing, preventing skin from cracking and sterilizing; the calendula has the functions of resisting bacteria and diminishing inflammation, can well inhibit the growth and reproduction of bacteria, has the prevention and treatment effects on bacterial infection of various outer skins, such as various inflammations of skin and mucous membrane, and also has the function of diminishing inflammation of otitis; the cornflower can separate 27 kinds of anti-inflammatory triterpene compounds, can treat dermatitis, and has inhibiting effect on induced allergy of skin; can enhance resistance of capillary vessel, inhibit capillary vessel permeability and has antiinflammatory effect; meanwhile, the composition can eliminate free radicals, has oxidation resistance and has the effect of relieving aging; the orchid extract liquid can be taken orally to play roles of moistening lung, promoting diuresis, removing dampness, clearing heat and detoxicating, and can be taken externally to effectively diminish inflammation, inhibit bacteria and promote wound healing.
Example 1:
the epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray comprises a spray bottle and double coptis chinensis compositions, wherein the double coptis chinensis compositions are prepared from the following raw materials in parts by weight:
20 parts of honeysuckle extract, 20 parts of baical skullcap root extract, 10 parts of weeping forsythia extract, 14 parts of passion flower extract, 5 parts of calendula extract, 5 parts of cornflower extract, 2 parts of orchid extract, 0.7 part of bisabolol, 0.3 part of kurarinone, 3 parts of purslane extract and 0.03 part of tea polyphenol.
The preparation method of the epidemic prevention antibactericide double coptis composition oral and nasal spray described in the embodiment 1 comprises the following steps:
s1, mixing a honeysuckle extract, a baical skullcap root extract, a weeping forsythia extract, a passion flower extract, a calendula extract, a cornflower extract, an orchid extract and a purslane extract at normal temperature, homogenizing, and stirring at the speed of 30 r/min;
s2, adding bisabolol, kurarinone and tea polyphenol into the mixed solution, and slowly stirring until the mixture is homogeneous, wherein the stirring speed is 30 r/min;
s3, performing a sampling test, and filling the qualified product into a spray bottle.
Example 2:
the epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray comprises a spray bottle and double coptis chinensis compositions, wherein the double coptis chinensis compositions are prepared from the following raw materials in parts by weight:
25 parts of honeysuckle extract, 15 parts of baical skullcap root extract, 15 parts of weeping forsythia extract, 12 parts of passion flower extract, 7 parts of calendula extract, 4 parts of cornflower extract, 3 parts of orchid extract, 0.6 part of bisabolol, 0.4 part of kurarinone, 2 parts of purslane extract and 0.04 part of tea polyphenol.
The preparation method of the epidemic prevention antibactericide double coptis composition oral and nasal spray described in the embodiment 2 comprises the following steps:
s1, mixing a honeysuckle extract, a baical skullcap root extract, a weeping forsythia extract, a passion flower extract, a calendula extract, a cornflower extract, an orchid extract and a purslane extract at normal temperature, homogenizing, and stirring at the speed of 30 r/min;
s2, adding bisabolol, kurarinone and tea polyphenol into the mixed solution, and slowly stirring until the mixture is homogeneous, wherein the stirring speed is 30 r/min;
s3, performing a sampling test, and filling the qualified product into a spray bottle.
Example 3:
the epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray comprises a spray bottle and double coptis chinensis compositions, wherein the double coptis chinensis compositions are prepared from the following raw materials in parts by weight:
30 parts of honeysuckle extract, 10 parts of baical skullcap root extract, 20 parts of weeping forsythia extract, 10 parts of passion flower extract, 10 parts of calendula extract, 3 parts of cornflower extract, 4 parts of orchid extract, 0.5 part of bisabolol, 0.6 part of kurarinone, 1 part of purslane extract and 0.05 part of tea polyphenol.
The preparation method of the epidemic prevention antibactericide double coptis composition oral and nasal spray described in the embodiment 3 comprises the following steps:
s1, mixing a honeysuckle extract, a baical skullcap root extract, a weeping forsythia extract, a passion flower extract, a calendula extract, a cornflower extract, an orchid extract and a purslane extract at normal temperature, homogenizing, and stirring at the speed of 30 r/min;
s2, adding bisabolol, kurarinone and tea polyphenol into the mixed solution, and slowly stirring until the mixture is homogeneous, wherein the stirring speed is 30 r/min;
s3, performing a sampling test, and filling the qualified product into a spray bottle.
Several test experiments were performed on the epidemic prevention and sterilization Shuanghuanglian composition oral-nasal spray prepared in examples 1-3.
Experimental example 1
Irritation investigation
The irritation inspection was performed on the Shuanghuanglian composition oral-nasal spray prepared in example 1-example 3 by using animal experiments. 40 experimental mice are randomly divided into 4 groups, and the multiple administration mode is the same as the single administration mode, and the continuous administration is carried out at the same part, the administration time and the metering are the same, and the continuous use is carried out for 7 days. Scoring is performed by referring to the skin irritation response scoring standard of the technical guidelines for chemical drug irritation, allergy and hemolysis research, and the average score is calculated, and the result is shown in table 1.
TABLE 1 average score of skin irritation for oral and nasal spray of Shuanghuanglian composition
Experimental results show that the Shuanghuanglian composition oral-nasal spray provided by the invention has a certain stimulation effect on the skin of an experimental mouse, but the irritation is not great and is within a reasonable range.
Experimental example 2
Colibacillus bacteriostasis experiment
The antibacterial effect (antibacterial rate%) of the Shuanghuanglian composition oral-nasal spray prepared in example 1-example 3 on different time nodes of escherichia coli diluted with diluent (PBS) was detected, and the test method was based on: the experimental temperature is 20-22 ℃ according to 2.1.11.3.2 item 2002 of disinfection technical Specification. The results are shown in Table 2.
For 1 minute | 2 minutes | 3 minutes | For 5 minutes | For 10 minutes | |
Example 1 | 81.79% | 84.26% | 88.37% | 92.63% | 95.18% |
Example 2 | 83.42% | 86.19% | 88.95% | 93.25% | 95.72% |
Example 3 | 82.53% | 85.94% | 91.06% | 92.84% | 95.53% |
TABLE 2 antibacterial effect of Shuanghuanglian composition oral-nasal spray on E.coli
Experimental results show that the Shuanghuanglian composition oral-nasal spray has remarkable antibacterial and bactericidal effects on escherichia coli.
The foregoing description is only illustrative of the present invention and is not intended to limit the scope of the invention, and all equivalent structures or equivalent processes or direct or indirect application in other related arts are included in the scope of the present invention.
Claims (10)
1. The epidemic prevention and sterilization double coptis chinensis composition oral-nasal spray is characterized by comprising a spray bottle and a double coptis chinensis composition, wherein the double coptis chinensis composition is prepared from the following raw materials:
honeysuckle extract, baical skullcap root extract, weeping forsythiae extract, passion flower extract, calendula extract, cornflower extract, orchid extract, bisabolol, kurarinone, purslane extract and tea polyphenol.
2. The epidemic prevention and sterilization double coptis composition oral and nasal spray according to claim 1, wherein the double coptis composition is prepared from the following raw materials in parts by weight:
20-30 parts of honeysuckle extract, 10-20 parts of baical skullcap root extract, 10-20 parts of weeping forsythia extract, 8-15 parts of passion flower extract, 5-10 parts of calendula extract, 3-5 parts of cornflower extract, 2-4 parts of orchid extract, 0.4-0.8 part of bisabolol, 0.3-0.6 part of kurarinone, 1-3 parts of purslane extract and 0.03-0.05 part of tea polyphenol.
3. The epidemic prevention and sterilization double coptis composition oral and nasal spray according to claim 2, wherein the double coptis composition is prepared from the following raw materials in parts by weight:
20 parts of honeysuckle extract, 20 parts of baical skullcap root extract, 10 parts of weeping forsythia extract, 14 parts of passion flower extract, 5 parts of calendula extract, 5 parts of cornflower extract, 2 parts of orchid extract, 0.7 part of bisabolol, 0.3 part of kurarinone, 3 parts of purslane extract and 0.03 part of tea polyphenol.
4. The epidemic prevention and sterilization double coptis composition oral and nasal spray according to claim 2, wherein the double coptis composition is prepared from the following raw materials in parts by weight:
25 parts of honeysuckle extract, 15 parts of baical skullcap root extract, 15 parts of weeping forsythia extract, 12 parts of passion flower extract, 7 parts of calendula extract, 4 parts of cornflower extract, 3 parts of orchid extract, 0.6 part of bisabolol, 0.4 part of kurarinone, 2 parts of purslane extract and 0.04 part of tea polyphenol.
5. The epidemic prevention and sterilization double coptis composition oral and nasal spray according to claim 2, wherein the double coptis composition is prepared from the following raw materials in parts by weight:
30 parts of honeysuckle extract, 10 parts of baical skullcap root extract, 20 parts of weeping forsythia extract, 10 parts of passion flower extract, 10 parts of calendula extract, 3 parts of cornflower extract, 4 parts of orchid extract, 0.5 part of bisabolol, 0.6 part of kurarinone, 1 part of purslane extract and 0.05 part of tea polyphenol.
6. The epidemic prevention and sterilization Shuanghuanglian composition oral-nasal spray of claim 1, wherein the honeysuckle extract, the baikal skullcap root extract, the weeping forsythiae capsule extract, the passion flower extract, the calendula extract, the cornflower extract, the orchid extract and the purslane extract are extracted by ethanol with concentration of 34% -60%.
7. The epidemic prevention antibactericide double coptis composition oral and nasal spray of claim 1, wherein the percentage of the fog drops with the particle size distribution of 2-5 μm to the total volume of the fog drops is more than 75%.
8. The epidemic prevention and sterilization double coptis composition oral and nasal spray according to claim 1, which is used for disinfection and bacteriostasis at the oral cavity and nasal cavity and for preventing bacterial or viral invasion infection.
9. The method for preparing the epidemic prevention antibactericide double coptis composition oral and nasal spray according to any one of claims 1 to 8, which is characterized by comprising the following steps:
s1, mixing a honeysuckle extract, a baical skullcap root extract, a weeping forsythia extract, a passion flower extract, a calendula extract, a cornflower extract, an orchid extract and a purslane extract at normal temperature, and homogenizing;
s2, adding bisabolol, kurarinone and tea polyphenol into the mixed solution, and stirring slowly until the mixture is homogeneous;
s3, performing a sampling test, and filling the qualified product into a spray bottle.
10. The method for preparing the epidemic prevention antibactericide double coptis composition oral and nasal spray according to claim 9, wherein in S1 and S2, the stirring speed is 20-40r/min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211701120.5A CN116531461A (en) | 2022-12-28 | 2022-12-28 | Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211701120.5A CN116531461A (en) | 2022-12-28 | 2022-12-28 | Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116531461A true CN116531461A (en) | 2023-08-04 |
Family
ID=87453055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211701120.5A Pending CN116531461A (en) | 2022-12-28 | 2022-12-28 | Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116531461A (en) |
-
2022
- 2022-12-28 CN CN202211701120.5A patent/CN116531461A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105504966A (en) | Novel lithographic plate offset printing ink | |
CN106938046A (en) | A kind of antibacterial peptide complex enzyme oral spray | |
CN108371191A (en) | A kind of air antiseptic and its preparation method and application | |
CN104096114B (en) | Throat clearing and moistening sugar | |
Abbass | Eucalyptus essential oil; an off-label use to protect the world from COVID-19 pandemic: Review-based hypotheses | |
KR20060037390A (en) | Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil | |
CN111317759A (en) | Traditional Chinese medicine anion disinfectant and preparation method thereof | |
CN110384725A (en) | A kind of preparation of Chinese traditional medicine composition and its activity extract for adjusting oral cavity flora | |
CN104295051B (en) | A kind of active ecological Environmental protection floor | |
CN103263679B (en) | The preparation method of the fragrant plant air scavenging solution of medicine of environment purification, strengthening respiratory system | |
RU2388481C2 (en) | Treatment-and-preventive agent for young farm animals; and method for prevention of respiratory diseases among calve and its application | |
CN106309746A (en) | Traditional Chinese medicine composition, preparation method thereof and oral health product | |
Hoffmann | Easy breathing: natural treatments for asthma, colds, flu, coughs, allergies, and sinusitis | |
CN106336730A (en) | Environment-friendly aqueous black ink | |
KR102251911B1 (en) | Silver ion bacteriostatic hand sanitizer and preparation method and application thereof | |
CN116531461A (en) | Epidemic prevention and sterilization double coptis chinensis composition oral and nasal spray and preparation method thereof | |
RU2461385C1 (en) | Method of preventing respiratory diseases in calves | |
CN104304629A (en) | Traditional Chinese medicine fragrant chewing gum | |
CN104274750B (en) | A kind of Chinese medicine composition for treating acute bronchitis, the infection of the upper respiratory tract | |
CN108403770A (en) | A kind of antibacterial cream for treating nasal cavity disease | |
CN114053331B (en) | Oral antibacterial composition, oral antibacterial liquid, application and preparation method | |
CN103877288A (en) | Biomedical film made of chitosan for nasopharyngitis and preparation method thereof | |
KR20190057727A (en) | Composition for improving bronchial health improved palatability | |
CN104206444B (en) | A kind of electric liquid device fragrant containing lavender natural and preparation method | |
CN112704697A (en) | Atomized liquid for resisting epidemic and maintaining respiratory tract health and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |